Premenstrual Dysphoric Disorder Awareness and Research Act of 2026
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, Premenstrual Dysphoric Disorder Awareness and Research Act of 2026, changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Government Operations, Education.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H874D0157D33D45DAB1CB185BD78AD091: 1. Short title This Act may be cited as the Premenstrual Dysphoric Disorder Awareness and Research Act of 2026.
- Section H3976E629088E411BA8F6C21DC547F4A2: 2. Findings Congress finds the following: Premenstrual Dysphoric Disorder (referred to in this section as PMDD) is a severe, chronic, and often disabling...
- Section HE817BF9602874C26A1F52921C916965B: 3. Research with respect to Premenstrual Dysphoric Disorder (PMDD) The Secretary of Health and Human Services (in this section referred to as the Secretary),...
- Section HBA2B5ECC584244AFAE5C11F00B145C4C: 4. Education and dissemination of information with respect to Premenstrual Dysphoric Disorder (PMDD) The Secretary shall carry out a public health awareness...
- Section H42C92CF0FE42490E94342E20D5F9995C: 5. Grants To train health professionals with respect to PMDD The Secretary shall award grants to eligible entities for the purpose described in subsection (b)....
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, Premenstrual Dysphoric Disorder Awareness and Research Act of 2026, changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Government Operations, Education
Primary Purpose
This bill, Premenstrual Dysphoric Disorder Awareness and Research Act of 2026, changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
In CommitteeReferred to the House Committee on Energy and Commerce.
Introduced in House
Ms. Ansari (for herself, Mrs. Beatty, Mr. Bell, Ms. Brownley, …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_administrator"
- → The Administrator identified in the operative section
- "secretary_of_health_and_human_services"
- → Secretary of Health and Human Services
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology